RBS’s Richard Roach, managing director of financial sponsors, and Malcolm Hassan, head of funds and asset management, discuss the impact of alternative lenders on the UK debt market with Alice Murray in a sponsored video roundtable
The UK lending markets have come back to life with a bang over the past 18 months, partly due to the emergence of direct lenders. This has arguably been one of the drivers behind increased UK dealflow. But how are these relatively new players impacting traditional banks such as RBS?
This video looks at why alternative lenders have been so successful in raising funds, and their impact on the lending market. It also explores how banks have reacted to these players, and Richard Roach hints at some exciting new developments for RBS.
If you would like to skip to individual questions and answers within in the video, use the index below. Just scroll the timeline in the video player above until you reach these points:
3:24 – Impact of debt funds on acquisition finance market
5:09 – Market concerns over the role of debt funds
6:31 – RBS announces multiple collaborations with debt funds
10:05 – Cov-lite deals and concerns about over-leverage
13:10 – The impact of regulation
14:51 – Outlook on interest rates
We would like to thank RBS for sponsoring this video.
Backers close a $18.6m round started in 2015 with an initial $10.6m capital injection
GP invests via its Nordic Capital Fund IX, which held a final close on €4.3bn in May 2018
Abalos Therapeutics is a biotechnology company focused on developing immuno-oncology therapeutics
Existing management team will lead the company's future growth and development